Study of PED-TAE treatment for thyroid disease
Part of Cancer, Hormones & metabolism clinical trials.
This study tracks people who have already received a new type of thyroid treatment called PED-TAE (pressure-enabled embolization) using the TriNav system. It aims to see how well this procedure works for various thyroid conditions, including overactive thyroid, large goiters, and benign nodules causing symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 89 years old.
- You have already had a procedure called PED-TAE (pressure-enabled embolization) using the TriNav system.
- You have a thyroid condition that is either: (1) hyperthyroidism from a toxic nodule or goiter, (2) a non-cancerous goiter or nodule causing symptoms like neck pain or trouble swallowing, (3) you are unable or unwilling to have surgery, radiation, or other ablation, or (4) you have a benign thyroid nodule (Bethesda 2-3) confirmed by two biopsies and a molecular test, and you declined surgery.
- You do not have kidney failure, severe contrast allergy, or pregnancy.
- You do not have Graves' disease, Hashimoto's thyroiditis, or certain abnormal blood vessel patterns in the neck.
- You have not had prior thyroid heat ablation.
- Your thyroid biopsy results are not suspicious for cancer (Bethesda 4-6).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-surgical procedure called thyroid artery embolization (TAE) to shrink a goiter that is pressing on your windpipe or throat. It may help if you cannot have surgery or prefer an alternative.
This trial tests a new procedure called nanosecond pulsed field ablation (nsPFA) to shrink benign thyroid nodules that are causing symptoms like tightness in the throat or trouble swallowing.
This trial tests a new device that uses nanosecond electrical pulses to treat benign thyroid nodules. It may be an option if you have a benign nodule causing symptoms like discomfort or anxiety, and you're looking for a non-surgical treatment.
This trial tests a minimally invasive procedure that blocks blood flow to large thyroid nodules, which can shrink them and relieve symptoms like trouble swallowing or cosmetic concerns. It's an option for people with benign nodules or Graves disease who want to avoid surgery or other treatments.
This trial tests whether a minimally invasive treatment called TACE (injecting small particles into blood vessels) can shrink large, benign thyroid nodules. It may be an option for people who want to avoid surgery but have nodules causing mild discomfort.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
Hear when a new Hyperthyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.